Prevention and treatment of metastatic disease in patients with thrombocytosis

摘要

The present invention relates to the use of the anti-megakaryotic agent anagrelide or a therapeutically active metabolite of anagrelide in the prevention and / or treatment of metastatic disease in cancer patients exhibiting paraneoplastic thrombocytosis.